Brant Point Investment Management LLC Makes New $1.50 Million Investment in Guardian Pharmacy Services, Inc. $GRDN

Brant Point Investment Management LLC bought a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the 2nd quarter, HoldingsChannel reports. The fund bought 70,210 shares of the company’s stock, valued at approximately $1,496,000.

Several other institutional investors and hedge funds have also made changes to their positions in GRDN. KLP Kapitalforvaltning AS bought a new position in shares of Guardian Pharmacy Services in the 2nd quarter worth about $75,000. Woodline Partners LP lifted its holdings in Guardian Pharmacy Services by 1.5% in the first quarter. Woodline Partners LP now owns 421,203 shares of the company’s stock worth $8,955,000 after acquiring an additional 6,083 shares during the last quarter. Geode Capital Management LLC boosted its stake in Guardian Pharmacy Services by 65.9% in the second quarter. Geode Capital Management LLC now owns 336,701 shares of the company’s stock valued at $7,177,000 after acquiring an additional 133,715 shares during the period. Peregrine Capital Management LLC grew its holdings in shares of Guardian Pharmacy Services by 21.4% during the second quarter. Peregrine Capital Management LLC now owns 214,379 shares of the company’s stock valued at $4,568,000 after purchasing an additional 37,840 shares during the last quarter. Finally, TimesSquare Capital Management LLC acquired a new stake in shares of Guardian Pharmacy Services during the 2nd quarter worth approximately $17,351,000.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on GRDN. Truist Financial boosted their price objective on Guardian Pharmacy Services from $30.00 to $34.00 and gave the company a “buy” rating in a research report on Friday, November 14th. Oppenheimer began coverage on shares of Guardian Pharmacy Services in a research note on Friday, October 10th. They set an “outperform” rating and a $30.00 target price for the company. Weiss Ratings restated a “hold (c)” rating on shares of Guardian Pharmacy Services in a research note on Monday, December 1st. Finally, Wall Street Zen raised Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a report on Monday, November 17th. Three investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $30.67.

Guardian Pharmacy Services Stock Up 1.3%

Shares of GRDN stock opened at $29.71 on Monday. The stock has a 50-day simple moving average of $27.47 and a 200 day simple moving average of $24.48. Guardian Pharmacy Services, Inc. has a fifty-two week low of $17.78 and a fifty-two week high of $37.43. The stock has a market capitalization of $1.88 billion, a P/E ratio of 47.15 and a beta of 0.95.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Monday, November 10th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The firm had revenue of $377.43 million for the quarter, compared to analysts’ expectations of $381.16 million. On average, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.